← Back to Clinical Trials
Recruiting NCT06499597

NCT06499597 Duke Activity Score Index in Obese Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06499597
Status Recruiting
Phase
Sponsor Harran University
Condition Obesity, Morbid
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-03-01
Primary Completion 2024-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-03-01 with a primary completion date of 2024-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Today, obesity is a global health problem and can lead to serious health complications. Bariatric surgery is recognized as an effective treatment option to achieve long-term weight loss and health improvement in overweight or obese individuals. However, appropriate tools are needed to assess the physical activity levels of patients before and after bariatric surgery and to guide rehabilitation processes after surgery. The Duke Activity Index (DAI) is a scale used to assess activities of daily living and was developed at Duke University Medical Center. The DAI has been widely used to determine patients' physical functioning and monitor their activity levels in various health conditions and post-surgical recovery processes. The aim of this study was to evaluate the psychometric properties of the DAI and to examine whether it is an effective tool for determining physical activity levels in patients who are candidates for bariatric surgery.

Eligibility Criteria

Inclusion Criteria: * Body mass index higher than 30 * No disease that may affect functional performance * Able to adapt to the tests to be applied Exclusion Criteria: * Recently hospitalized due to a condition that may make it difficult to perform the test * Inability to perform exercise tests due to neurological or musculoskeletal disorders * Uncontrollable medical conditions (such as lung or cardiovascular disease) * Dysfunction of the vestibular system or eyes

Contact & Investigator

Central Contact

Zeynal Yasacı

✉ zeynalyasaci@gmail.com

📞 05075409791

Frequently Asked Questions

Who can join the NCT06499597 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06499597 currently recruiting?

Yes, NCT06499597 is actively recruiting participants. Contact the research team at zeynalyasaci@gmail.com for enrollment information.

Where is the NCT06499597 trial being conducted?

This trial is being conducted at Sanliurfa, Turkey (Türkiye).

Who is sponsoring the NCT06499597 clinical trial?

NCT06499597 is sponsored by Harran University. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology